Abstract
Background
IgA nephropathy (IgAN) is one of the most frequently occurring types of chronic glomerulonephritis. Previous analyses have revealed that a major pathogen of dental caries, Streptococcus mutans [which expresses collagen-binding protein (Cnm) on its surface], is involved in the pathogenesis of IgAN.
Methods
Cnm-positive S. mutans isolated from a patient with IgAN was intravenously administered to specific pathogen-free Sprague–Dawley rats to evaluate their kidney conditions.
Results
The urinary protein level of the S. mutans group reached a plateau at 30 days, with increased numbers of mesangial cells and an increased mesangial matrix. The numbers of rats with IgA-positive and/or C3-positive glomeruli were significantly greater in the S. mutans group than in the control group at 45 days (P < 0.05). Electron microscopy analyses revealed electron-dense depositions in the mesangial area among rats in the S. mutans group. There were significantly more CD68-positive cells (macrophages) in the glomeruli of the S. mutans group than in the glomeruli of the control group during the late phase (P < 0.05), similar to the findings in patients with IgAN.
Conclusion
Our results suggested that intravenous administration of Cnm-positive S. mutans caused transient induction of IgAN-like lesions in rats.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Immunoglobulin A nephropathy (IgAN) is the most common chronic form of primary glomerulonephritis [1, 2]. It has been reported that 30–40% of patients with IgAN exhibit progression to end-stage kidney disease within 20 years [1, 2]. However, there is no specific treatment for IgAN, because the underlying pathogenesis of the disease has not been fully elucidated [3]. The pathology of IgAN is known to be characterised by IgA deposition in glomerular mesangial cells. Some patients with IgAN (approximately 30%, primarily young individuals) have a clear clinical history of disease exacerbation after tonsillitis and upper respiratory or gastrointestinal infections [4, 5]. Several bacterial species have been proposed to be associated with the pathogenesis of IgAN [4, 6,7,8,9,10], indicating that infection is likely to play a major underlying role in some affected patients.
Streptococcus mutans, a Gram-positive facultative anaerobic bacterial species, is a major pathogen of human dental caries [11]. S. mutans strains expressing the collagen-binding protein (Cnm) on their cell surface exhibit a binding ability for the extracellular matrix; thus, Cnm may be a virulence factor in several diseases such as infective endocarditis [12], aggravated cerebral haemorrhaging [13,14,15], non-alcoholic steatohepatitis [16], and inflammatory bowel disease [11]. Furthermore, the results of our recent studies suggest that Cnm-positive S. mutans strains are associated with IgAN [17,18,19].
Several in vivo studies in the 1980s and 1990s hypothesised a correlation between S. mutans and nephritis [20, 21]; however, to the best of our knowledge, there have been no subsequent reports regarding this relationship. We recently found that the proportion of Cnm-positive S. mutans strains isolated from the oral cavity was significantly greater in patients with IgAN than in healthy controls; moreover, the presence of Cnm-positive S. mutans and the dental caries status was both associated with exacerbation of urinary protein levels in patients with IgAN [18]. However, the detailed mechanism associated with IgAN remains unknown, because no available experimental animal models have demonstrated that Cnm-positive S. mutans infection induces IgAN. Accordingly, this study was performed to investigate whether Cnm-positive S. mutans contribute to the onset of IgA-like renal lesions, and to establish a rat model of IgAN related to infection.
Materials and methods
Bacterial strain and culture medium
S. mutans strain SN74 (serotype e) was isolated from the oral cavity of a patient with severe IgAN about 5 years ago. The patient was 60 s. His serum creatinine level was 1.02 mg/dl, estimated glomerular filtration rate was 58 ml/min, and urinary protein grade was 1 + ; he had no urinary occult blood and no history of gross hematuria. The patient was prescribed a renin–angiotensin system inhibitor at that time. Approximately 15 years ago, the patient had undergone renal biopsy; the findings had supported a diagnosis of IgAN, with Oxford classification M0E1S1T1C1. At the time of diagnosis, his serum creatinine level was 1.12 mg/dl, estimated glomerular filtration rate was 54 ml/min, urinary protein grade was 3 + (2.93 g/g Cre), and urinary occult blood grade was 2 + . Steroid therapy was administered for 1 year about 15 years ago. The SN74 strain was confirmed to express Cnm on its cell surface. The strain was cultured on Mitis-Salivarius agar (Difco Laboratories, Detroit, MI, USA) plates containing bacitracin (0.2 U/ml; Sigma Chemical Co., St. Louis, MO, USA) or brain heart infusion (Difco) broth.
Animal experiments
All rats were treated humanely, in accordance with National Institutes of Health and AERI-BBRI Animal Care and Use Committee guidelines. All procedures used in the present study were approved by the Animal Care and Use Committee of Okayama University. The effects of intravenous administration of S. mutans were analysed in a rat model, as described previously [22] with some modifications [11, 16, 23]. Briefly, specific pathogen-free Sprague–Dawley rats (male, 4 weeks old; Japan CLEA, Tokyo, Japan) were randomly divided into control and S. mutans groups. Rats were allowed free access to water and food throughout the experimental period. Rats were fed an MF diet (ORIENTAL YEAST CO., Ltd, Tokyo, Japan). Rats received intravenous injections (through the jugular vein) of S. mutans (1 × 108 colony-forming units) suspended in 100 µl phosphate-buffered saline (PBS) or PBS alone (i.e., without added bacteria).
The rats were euthanised at 15, 30, 45, and 60 days after infection; their kidneys were then removed. Urinary levels of protein and creatinine were measured by Nagahama Lifescience (ORIENTAL YEAST CO., Ltd, Shiga, Japan). Serum levels of creatinine, albumin, and blood urea nitrogen were also measured by Nagahama Lifescience.
Tissue samples were fixed in 3.7% formaldehyde (diluted in PBS), embedded in paraffin, and cut into 3 µm-thick sections for histopathological analysis. Periodic acid-Schiff staining was performed to evaluate increases of mesangial cells and mesangial matrix in glomeruli. Mesangial proliferation scores were then calculated based on the proportion of glomeruli with mesangial cells and matrix proliferation among 50 glomeruli in Periodic acid–Schiff-stained sections. Additionally, alterations in IgA, C3, and CD34 expression patterns in tissue samples were detected using standard immunohistochemical techniques with IgA-, C3-, and CD34 (vascular endothelial cell marker)-specific antibodies. The primary antibodies used were Purified Mouse Anti-Rat IgA (BD Biosciences, Franklin Lakes, NJ, USA), anti-C3 (B-9) (sc-28294; Santa Cruz Biotechnology, Dallas, TX, USA), and anti-CD34 (EP373Y) (ab81289; Abcam, Cambridge, MA, USA) antibodies. Secondary antibodies were Donkey Anti-Mouse IgG H&L (Alexa Fluor 488) preadsorbed (ab150109; Abcam) and Donkey Anti-Rabbit IgG H&L (Alexa Fluor 647) (ab150075; Abcam). Fluorescence immunostaining was performed using these antibodies. Stained sections were observed using an all-in-one fluorescence microscope (BZ-X700; Keyence, Osaka, Japan).
The distributions of immunocompetent cells in the kidney were analysed by evaluating alterations of CD43 (neutrophil marker) and CD68 (macrophage marker) in tissue samples using standard immunohistochemical techniques with CD43- and CD68-specific antibodies, respectively [24]. The primary antibodies used were a Purified Mouse Anti-Rat CD43 (W3/13) (BD Biosciences) and anti-CD68 (ED1) (BD Biosciences) antibodies. Histofine simple stain rat MAX-PO (M) was used as the secondary antibody. Twenty glomeruli were selected in random images obtained at low magnification; then, the proportions of glomeruli that exhibited positive staining results for each antibody were determined. Subsequently, results for the S. mutans group were expressed as relative ratios; the average values of the control group at each time point were regarded as 1.0. Images were analysed with ImageJ (National Institutes of Health, Bethesda, MD, USA) to determine the ratios of CD43- and CD68-positive areas to whole glomeruli.
Transmission electron microscopy
For pre-fixation, excised kidney tissue specimens were immersed in a solution of 2% glutaraldehyde and 2% paraformaldehyde in PBS (0.1 M, pH 7.4) for 16–18 h. Post-fixation was then performed in 2% osmium tetroxide for 1.5 h. After specimens had been washed with PBS, they were dehydrated in a graded ethanol series and embedded in low-viscosity resin (Spurr resin; Polysciences, Warrington, PA, USA). Eighty nanometre ultrathin sections were then prepared using an ultramicrotome (EM-UC 7; Leica, Tokyo, Japan); sections were stained with uranyl acetate and lead citrate. Specimens were observed under a transmission electron microscope (H-7650; HITACHI, Tokyo, Japan).
Statistical analyses
Statistical analyses were performed using GraphPad Prism 8 Statistics Software (GraphPad, Inc., La Jolla, CA, USA). All results are presented as the mean ± standard error. Differences in whole-body weight serum levels, mesangial proliferation scores, and the positive area ratios of CD43 and CD68 were assessed using Student’s t test; differences in urinary protein were assessed by Thompson’s rejection test, followed by Fisher’s exact test. In addition, positive immunohistochemical staining results were compared using Fisher’s exact test. P values of less than 0.05 were considered statistically significant.
Results
Clinical characteristics of rats
First, we compared the systemic conditions of specific pathogen-free Sprague–Dawley rats that had been administered Cnm-positive S. mutans (1 × 108 colony-forming units) isolated from a patient with IgAN (strain SN74; S. mutans group) and those of control rats that had been administered PBS (control group). There were no significant differences in whole-body weights between S. mutans and control groups throughout the study (Table 1). However, the values of urinary protein at 30 days, standardised to the values of creatinine, were significantly greater in the S. mutans group than in the control group (P < 0.01) (Fig. 1). In contrast, there were no significant differences between the two groups at 15, 45, and 60 days. Analysis of haematuria (erythrocytes in urine) revealed no significant differences between groups. Table 1 shows the values of representative blood biochemical parameters related to kidney conditions. There were no significant differences in serum albumin level between the two groups throughout the study. However, serum blood urea nitrogen values were significantly greater in the S. mutans group than in the control group at 30 days (P < 0.05); conversely, there were no significant differences between the two groups in terms of serum blood urea nitrogen values at 15, 45, and 60 days. At 45 days, significantly greater serum creatinine values were observed in the control group than in the S. mutans group, whereas there were no significant differences between the groups at 15, 30, and 60 days.
Histopathological and immunochemical findings
Rats were sacrificed at each time point and their kidneys were removed for histopathological examinations. Periodic acid–Schiff staining of kidney sections demonstrated increases in mesangial cell numbers and an increased mesangial matrix at 30 and 45 days in the S. mutans group; however, these phenomena were not observed at 15 and 60 days (Fig. 2). In addition, mesangial proliferation scores were significantly greater in the S. mutans group than in the control group at 30 and 45 days (P < 0.001 and P < 0.01, respectively). Notably, there were no significant differences in mesangial proliferation scores between the two groups at 15 and 60 days. Fluorescence immunostaining using an anti-IgA antibody revealed deposition of IgA in the mesangial area of the S. mutans group at 30 and 45 days, whereas deposition was not observed at 15 and 60 days (Fig. 3). Fluorescence immunostaining results for CD34 and C3 exhibited partial overlap. Fluorescence immunostaining using an anti-C3 antibody indicated both mesangial and subendothelial deposition of C3 in the S. mutans group at 30 and 45 days (Fig. 4). Overall, there were significantly greater proportions of sections with IgA and/or C3 deposition in the S. mutans group than in the control group at 45 days (P < 0.05); no significant differences were observed at 15, 30, and 60 days (Table 2).
Taken together, the findings indicate that rats administered Cnm-positive S. mutans via the jugular vein demonstrated pathological changes suggestive of IgAN-like nephritis at 30 and 45 days, which recovered at 60 days.
Electron microscopy findings
Electron microscopy analyses demonstrated mesangial deposition in renal glomeruli at 45 days in the S. mutans group (Fig. 5). In addition, a hump was observed in the subepithelial region.
Distribution of immunocompetent cells in the kidney
Immunochemical staining using an anti-CD43 antibody revealed deposition of neutrophils and lymphocytes in glomeruli. There were no significant differences in this deposition between S. mutans and control groups during any period (Fig. 6a). In contrast, immunochemical staining using an anti-CD68 antibody demonstrated prominent deposition of macrophages in glomeruli in the S. mutans group. The CD68-positive cell proportion was significantly greater in the S. mutans group than in the control group at 30, 45, and 60 days (P < 0.05, P < 0.05, and P < 0.01, respectively) (Fig. 6b).
Discussion
To the best of our knowledge, this is the first study to demonstrate that intravenous administration of S. mutans caused transient induction of IgAN-like lesions in rats. The association of S. mutans with nephritis was first reported in 1985; intravenous administration of S. mutans was found to induce the production of immune complexes, leading to nephritis-like lesions in rabbits [20]. Moreover, a study in 1995 revealed that intraperitoneal administration of S. mutans led to elevated serum rheumatoid factor levels, which caused nephritis in rabbits [21]. In terms of animal models of spontaneous IgAN, the HIGA mouse [25] and gddy mouse [26] are well known. However, there have been no reports of IgAN-like lesions in healthy animals that received intravenous administration of bacteria. In the present study, we selected a Cnm-positive S. mutans strain for administration to healthy rats, because this type of strain is frequently present in the oral cavity of patients with IgAN [17, 18].
The dose of Cnm-positive S. mutans used in this study was determined based on our previous mouse models of cerebral haemorrhage [13], ulcerative colitis [11], and non-alcoholic steatohepatitis [23], as well as a rat model of infective endocarditis [22]. S. mutans has been proposed to enter the bloodstream via invasive dental treatment, such as tooth extraction [27]. As expected, IgAN-like lesions were found at 30 and 45 days, but disappeared at 60 days. It is reasonable to speculate that administration of a single intravenous dose of S. mutans to healthy rats caused transient induction of the IgAN-like lesions. We found increases in transient proteinuria, mesangial cells, and mesangial matrix in histopathological examinations, mesangial IgA and C3 deposition and partial C3 subendothelial deposition in fluorescence immunostaining, and mesangial deposition and a hump in electron microscopy analyses. C3 deposition was more frequently identified than IgA deposition in rats at 45 days. These features had characteristics similar to those of IgA-dominant infection related to glomerulonephritis (IRGN), in which bacterial infection induces lesions with IgAN-like pathology [28].
It has been reported that neutrophils and macrophages are predominantly found in IRGN, compared with early IgAN; moreover, a reduction of macrophages occurs in IRGN, whereas macrophage infiltration in IgAN continues until the late phase [24]. In the present study, there were no significant differences in CD43-positive cell proportions between S. mutans and control groups during any period. In contrast, the CD68-positive cell proportion was significantly greater in the S. mutans group at 30, 45, and 60 days; the proportion gradually reduced in the late phase. These results suggest that the lesions in this model have some features similar to those of IgAN in human patients.
A proposed hypothesis regarding the mechanism of onset and development of IgAN involves respiratory sensitisation by bacterial antigens derived from Escherichia coli, Pseudomonas aeruginosa, Haemophilus parainfluenzae, and methicillin-resistant Staphylococcus aureus in the upper airway mucosal epithelium, based on various clinical symptoms in patients with IgAN [6, 29,30,31]. When bacteria invade the body, the immune defense mechanism is primarily influenced by the bacterial species and bacterial components of the cell wall (e.g., proteins and polysaccharides), which could be important target antigens for antibody reactions [29,30,31]; Cnm may constitute one of these antigens. The mucosal immune disorder caused by bacterial infection is presumed to induce dysfunction in remote glomerular tissues [6, 32, 33]. Indeed, upper respiratory infection is reportedly frequent in patients with acute IgAN [34]. Thus, persistent contact with a specific type of S. mutans could lead to persistent infection that involves overproduction of IgA and production of IgA with abnormal glycans, thereby causing onset of IgAN [35].
In summary, our study demonstrated that the administration of Cnm-positive S. mutans caused transient induction of IgAN-like lesions in rats. However, the mechanism underlying these lesions remains unknown and should be investigated in future studies. In addition, bacterial invasion of the bloodstream in the present model may reflect entry during invasive dental procedures (e.g., tooth extraction). Other models of chronic infection by S. mutans in rats (e.g., severe dental caries that extend to the pulp space and cause persistent bacteraemia) should be examined in future studies.
References
D’Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987;64:709–27.
Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med. 1988;84:129–32.
Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368:2402–14.
Rollino C, Vischini G, Coppo R. IgA nephropathy and infections. J Nephrol. 2016;29:463–8.
Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347:738–48.
Suzuki S, Nakatomi Y, Sato H, Tsukada H, Arakawa M. Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet. 1994;343:12–6.
Kusano K, Tokunaga O, Ando T, Inokuchi A. Helicobacter pylori in the palatine tonsils of patients with IgA nephropathy compared with those of patients with recurrent pharyngotonsillitis. Hum Pathol. 2007;38:1788–97.
Iwama H, Horikoshi S, Shirato I, Tomino Y. Epstein-barr virus detection in kidney biopsy specimens correlates with glomerular mesangial injury. Am J Kidney Dis. 1998;32:785–93.
Koyama A, Sharmin S, Sakurai H, Shimizu Y, Hirayama K, Usui J, Nagata M, Yoh K, Yamagata K, Muro K, Kobayashi M, Ohtani K, Shimizu T, Shimizu T. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int. 2004;66:121–32.
Nagasawa Y, Iio K, Fukuda S, Date Y, Iwatani H, Yamamoto R, Horii A, Inohara H, Imai E, Nakanishi T, Ohno H, Rakugi H, Isaka Y. Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment. PLoS ONE. 2014;9:e81636.
Kojima A, Nakano K, Wada K, Takahashi H, Katayama K, Yoneda M, Higurashi T, Nomura R, Hokamura K, Muranaka Y, Matsuhashi N, Umemura K, Kamisaki Y, Nakajima A, Ooshima T. Infection of specific strains of Streptococcus mutans, oral bacteria, confers a risk of ulcerative colitis. Sci Rep. 2012;2:332.
Nomura R, Naka S, Nemoto H, Otsugu M, Nakamura S, Ooshima T, Nakano K. Potential high virulence for infective endocarditis in Streptococcus mutans strains with collagen-binding proteins but lacking PA expression. Arch Oral Biol. 2013;58:1627–34.
Nakano K, Hokamura K, Taniguchi N, Wada K, Kudo C, Nomura R, Kojima A, Naka S, Muranaka Y, Thura M, Nakajima A, Masuda K, Nakagawa I, Speziale P, Shimada N, Amano A, Kamisaki Y, Tanaka T, Umemura K, Ooshima T. The collagen-binding protein of Streptococcus mutans is involved in haemorrhagic stroke. Nat Commun. 2011;2:485.
Tonomura S, Ihara M, Kawano T, Tanaka T, Okuno Y, Saito S, Friedland RP, Kuriyama N, Nomura R, Watanabe Y, Nakano K, Toyoda K, Nagatsuka K. Intracerebral hemorrhage and deep microbleeds associated with cnm-positive Streptococcus mutans; a hospital cohort study. Sci Rep. 2016;6:20074.
Watanabe I, Kuriyama N, Miyatani F, Nomura R, Naka S, Nakano K, Ihara M, Iwai K, Matsui D, Ozaki E, Koyama T, Nishigaki M, Yamamoto T, Tamura A, Mizuno T, Akazawa K, Takada A, Takeda K, Yamada K, Nakagawa M, Tanaka T, Kanamura N, Friedland RP, Watanabe Y. Oral Cnm-positive Streptococcus mutans expressing collagen binding activity is a risk factor for cerebral microbleeds and cognitive impairment. Sci Rep. 2016;6:38561.
Naka S, Nomura R, Takashima Y, Okawa R, Ooshima T, Nakano K. A specific Streptococcus mutans strain aggravates non-alcoholic fatty liver disease. Oral Dis. 2014;20:700–6.
Misaki T, Naka S, Kuroda K, Nomura R, Shiooka T, Naito Y, Suzuki Y, Yasuda H, Isozaki T, Nakano K. Distribution of Streptococcus mutans strains with collagen-binding proteins in the oral cavity of IgA nephropathy patients. Clin Exp Nephrol. 2015;19:844–50.
Misaki T, Naka S, Hatakeyama R, Fukunaga A, Nomura R, Isozaki T, Nakano K. Presence of Streptococcus mutans strains harbouring the cnm gene correlates with dental caries status and IgA nephropathy conditions. Sci Rep. 2016;6:36455.
Misaki T, Naka S, Wato K, Hatakeyama R, Nagasawa Y, Ito S, Inaba H, Nomura R, Matsumoto-Nakano M, Nakano K. Campylobacter rectus in the oral cavity correlates with proteinuria in immunoglobulin A nephropathy patients. Nephron. 2018;139:143–9.
Albini B, Nisengard RJ, Glurich I, Neiders ME, Stinson MW. Streptococcus mutans-induced nephritis in rabbits. Am J Pathol. 1985;118:408–18.
Miyata M, Glurich I, Kasukawa R, Milgrom F, Stinson M, Albini B. Streptococcus-mutans-induced nephritis in rabbits: rheumatoid factors and nephritogenicity. Int Arch Allergy Immunol. 1995;108:360–7.
Nomura R, Otsugu M, Naka S, Teramoto N, Kojima A, Muranaka Y, Matsumoto-Nakano M, Ooshima T, Nakano K. Contribution of Streptococcus mutans serotype k strains interaction with fibrinogen to the pathogenicity of infective endocarditis. Infect Immun. 2014;82:5223–344.
Naka S, Wato K, Hatakeyama R, Okawa R, Nomura R, Nakano K. Longitudinal comparison of Streptococcus mutans-induced aggravation of non-alcoholic steatohepatitis in mice. J Oral Microbiol. 2018;10:1428005.
Hisano S, Sasatomi Y, Kiyoshi Y, Takebayashi S. Macrophage subclasses and proliferation in childhood IgA glomerulonephritis. Am J Kidney Dis. 2001;37:712–9.
Miyawaki S, Muso E, Takeuchi E, Matsushima H, Shibata Y, Sasayama S, Yoshida H. Selective breeding for high serum IgA levels from noninbred ddY mice: isolation of a strain with an early onset of glomerular IgA deposition. Nephron. 1997;76:201–7.
Suzuki Y, Tomino Y. Potential immunopathogenic role of the mucosa-bone marrow axis in IgA nephropathy: insights from animal models. Semin Nephrol. 2008;28:66–7.
Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacterima associated with toothbrushing and dental extraction. Circulation. 2008;117:3118–255.
Nasr SH, D’Agati VD. IgA-dominant postinfectious glomerulonephritis: a new twist on an old disease. Nephron Clin Prac. 2011;119:c18–25.
Woodroffe AJ, Gormly AA, McKenzie PE, Wootton AM, Thompson AJ, Seymour AE, Clarkson AR. Immunologic studies in IgA nephropathy. Kidney Int. 1980;18:366–74.
Endo Y, Hara M. Glomerular IgA deposition in pulmonary diseases. Kidney Int. 1986;29:557–62.
Koyama A, Kobayashi M, Yamaguchi N, Yamagata K, Takano K, Nakajima M, Irie F, Goto M, Igarashi M, Iitsuka T, Aoki Y, Sakurai H, Sakurayama N, Fukao K. Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int. 1995;47:207–16.
Fujieda S, Suzuki S, Sunaga H, Yamamoto H, Seki M, Sugimoto H, Saito H. Production of interferon-gamma by tonsillar mononuclear cells in IgA nephropathy patients. Acta Otolaryngol. 2000;120:649–54.
Floege J, Feehally J. The mucosa-kidney axis IgA nephropathy. Nat Rev Nephrol. 2016;12:147–56.
Suzuki S, Sato H, Kobayashi H, Takayama R, Murayama Y, Ogino S, Ueno H, Inomata A, Nishi S, Saito T, In H, Arakawa M. Comparative study of IgA nephropathy with acute and insidious onset. Clinical, laboratory and pathological findings. Am J Nephrol. 1992;12:22–8.
Novak J, Barratt J, Julian BA, Renfrow MB. Aberrant glycosylation of the IgA1 molecule in IgA nephropathy. Semin Nephrol. 2018;38:461–76.
Acknowledgements
This study was funded by Grants-in-aid for Scientific Research from the Japan Society for Promotion of Science (17K11959 to SN, 19K10098 to TM, and 18H03010 to KN). We thank Yumiko Morishita, Mika Monobe, and Miki Kajino (Central Research Laboratory, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences) for assistance with preparing tissue sections; we thank Masumi Furutani (Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences) for assistance with electron microscopy analyses.
Author information
Authors and Affiliations
Contributions
SN, KW, and TM designed the entire study under the supervision of KN. SN, KW, TM, SI, YN, RN, and MM-N performed the animal experiment; KW performed the statistical analysis. SN and KN wrote the manuscript, which all authors read and approved.
Corresponding author
Ethics declarations
Conflict of interest
The authors have declared that no conflict of interest exists.
Ethical approval
All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted (IRB approval number OKU-2017420).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Shuhei Naka, Kaoruko Wato, and Taro Misaki are contributed equally to this study.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Naka, S., Wato, K., Misaki, T. et al. Intravenous administration of Streptococcus mutans induces IgA nephropathy-like lesions. Clin Exp Nephrol 24, 1122–1131 (2020). https://doi.org/10.1007/s10157-020-01961-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-020-01961-1